|
| |
TRA@
| Symbol: | TRA@ | | Name(s): | T cell receptor alpha locus | | Type: | protein-coding | | Organism: | Homo sapiens | | Synonyms: | FLJ22602, MGC117436, MGC22624, MGC23964, MGC71411, TCRA, TCRD, TRA, TRDD3 | | Links: |
Pubmed,
Entrez Gene,
GeneCards,
BioGPS,
Map Viewer.
|
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 11142503 |
Observational study of gene-disease association. (HuGE Navigator) |
| 17785774 |
CD4positive CD25high regulatory T cells showing immunosuppressive functions use a large unrestricted alpha beta T cell receptor repertoire, the size and diversity of which are closely similar to those of CD4-positive CD25negative T cells. |
| 12444131 |
Self Ag recognition is mediated predominantly by TCR-alpha. |
| 17082594 |
T cell receptor alpha-chain usage plays a critical role in controlling major histocompatiblity complex (MHC) restriction between closely related allomorphs. |
| 16424183 |
Data are compatible with an instructive role for the TCR in alphabeta vs gammadelta lineage commitment, with gammadelta development as the default pathway for human thymocyte development. |
| 17015149 |
different enzymatic activities operate during recombination of TCRA and TCRD genes, although they are located within the same genetic locus |
| 12473666 |
constitutive pre-TCR down-modulation regulates pre-TCR surface expression levels and hence the extent of ligand-independent signaling through the pre-TCR |
| 11920559 |
Human T cells potentially recognize through the alpha beta TCR HLA-E molecules that bind to class I- and virus-derived peptides. |
| 17391765 |
T cell receptor V-J alpha recombination in the thymus is not random but depends on the reciprocal V alpha and J alpha position within the locus. |
| 15128794 |
Transgenic expression of the natural killer (NK) T cell-specific TCR alpha-chain Valpha14Jalpha18 leads to a complete restoration of NK T cell numbers in tyrosine kinase Fyn-deficient mice. | →View more information from publications. |
Press Releases on TRA@:
|
 |
| Schering-Plough Reports Financial Results for 2009 Third Quarter |
22nd October, 2009 |
Schering-Plough Corporation |
-- New product launches in Japan, the world's second largest pharmaceutical
market, including ASMANEX (mometasone furoate) for asthma and REMERON
(mirtazapine) for major
|
| Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study |
12th March, 2009 |
Schering-Plough Corporation |
A Phase II Study Published in The Lancet of Fast-Tracked Antiplatelet Agent Showed No Increase in TIMI Major and Minor Bleeding and was Well Tolerated When Given With Standard
|
| Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects |
24th November, 2008 |
Schering-Plough Corporation |
KENILWORTH, N.J., Nov. 24 /PRNewswire-FirstCall/ -- Leaders of Schering-Plough Corporation (NYSE: SGP) today provided an update for investors on the company's research pipeline, highlighting
|
| Schering-Plough Reports Financial Results for Second Quarter of 2008 |
21st July, 2008 |
Schering-Plough Corporation |
KENILWORTH, N.J., July 21 /PRNewswire-FirstCall/ -- Schering-Plough
Corporation (NYSE: SGP) today reported financial results for the second
quarter of 2008.
"We are very
|
BioNews Results for TRA@:  | |
| Merck Announces Completion of Patient Enrollment in Phase III TRA-2P-TIMI 50 Trial of SCH 530348, a Novel, Oral Antiplatelet PAR-1 Inhibitor |
Business Wire UK: Nov 13 2009 1:41PM Matching: tra
|
| Merck Announces Completion of Patient Enrollment in Phase III TRA-2P-TIMI 50 Trial of SCH 530348, a Novel, O |
Business Wire: Nov 13 2009 1:41PM Matching: tra
|
| Merck Announces Completion of Patient Enrollment in Phase III TRA-2P-TIMI 50 Trial of SCH 530348, a Novel, Oral Antiplatelet PAR-1 Inhibitor |
FinanzNachrichten.de: Nov 13 2009 1:41PM Matching: tra
|
| Merck Announces Completion of Patient Enrollment in Phase III TRA-2P-TIMI 50 Trial of SCH 530348, a Novel, Oral Antiplatelet PAR-1 Inhibitor |
Stockwatch: Nov 13 2009 1:40PM Matching: tra
|
| Merck Announces Completion of Patient Enrollment in Phase III TRA-2P-TIMI 50 Trial of SCH 530348, a Novel, Oral Antiplatelet PAR-1 Inhibitor |
Yahoo! Canada: Nov 13 2009 5:02PM Matching: tra
|
| Promote your company here: BioNewsCast - Press Release Distribution | →View more news. |
TRA@ results (if any) from reagent suppliers | 
|
Search Bioportfolio and other Life Science Sites for TRA@,
or search for TRA@ on BioPortfolio's antibody search engine.
This page has been viewed 207 times
Recent Search Terms used to find this page: TRA@ protein | receptor tra 1 | tra-1-81 antibody | recombination in the TRA locus human | pennyomega.com | TCRA/TCRD | t cell receptor alpha locus tra | what is an alpha locus | Color electrophoretic display - US Patent 7564615 | .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
